Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

被引：301

作者：

Mallbris L. ^{[1
,3
]}

Akre O. ^{[2
]}

Granath F. ^{[2
]}

Yin L. ^{[2
]}

Lindelöf B.

Ekbom A. ^{[2
]}

Ståhle-Bäckdahl M.

机构：

[1] Dermatology Unit, Department of Medicine, Karolinska Institute, Stockholm

[2] Clinical Epidemiology Unit, Department of Medicine, Karolinska Institute, Stockholm

[3] Dermatology Unit, Karolinska Hospital

来源：

European Journal of Epidemiology | 2004年 / 19卷 / 3期

关键词：

Atherosclerosis; Cardiovascular death; Epidemiology; Inflammation; Psoriasis;

D O I：

10.1023/B:EJEP.0000020447.59150.f9

中图分类号：

学科分类号：

摘要：

We have conducted a historical cohort study to assess cardiovascular mortality among psoriasis patients. Using the Swedish Inpatient Registry, we selected 8991 patients hospitalized for psoriasis at dermatological wards. To represent an outpatient cohort, 19,757 members of the Swedish Psoriasis Association were selected. Mortality from cardiovascular diseases was compared with the general population. We found no increased cardiovascular mortality among outpatients with psoriasis (standardized mortality ratio, SMR 0.94; 95% confidence interval, CI: 0.89-0.99). The overall risk among inpatients admitted at least once was increased by 50% (SMR 1.52; 95% CI: 1.44-1.60). The excess risk increased with increasing number of hospital admissions (p for trend <0.001). Cardiovascular mortality was higher among those admitted at younger ages (p for trend <0.001; SMR 2.62, 95% CI: 1.91-3.49, for patients aged 20 to 39 years at first admission). Young age at first admission appeared to further increase the risk among those who were repeatedly admitted. We conclude that a diagnosis of psoriasis per se does not appear to increase the risk for cardiovascular mortality. Severe psoriasis, however, here measured as repeated admissions, and early age at first admission, is associated with increased risk for cardiovascular death.

引用

页码：225 / 230

页数：5

共 29 条

[1]

Henseler T., Christophers E., Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris, J Am Acad Dermatol, 13, pp. 450-456, (1985)

[2]

McDonald C.J., Calabresi P., Psoriasis and occlusive vascular disease, Br J Dermatol, 99, pp. 469-475, (1978)

[3]

Henseler T., Christophers E., Disease concomitance in psoriasis, J Am Acad Dermatol, 32, pp. 982-986, (1995)

[4]

Poikolainen K., Karvonen J., Pukkala E., Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis, Arch Dermatol, 135, pp. 1490-1493, (1999)

[5]

Stern R.S., Lange R., Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 Years prospective experience in a cohort of 1380 patients, J Invest Dermatol, 91, pp. 197-201, (1988)

[6]

Rocha-Pereira P., Santos-Silva A., Rebelo I., Figueiredo A., Quintanilha A., Teixeira F., Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease, Clin Chim Acta, 303, pp. 33-39, (2001)

[7]

Seckin D., Tokgozoglu L., Akkaya S., Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis?, J Am Acad Dermatol, 31, 3 PART 1, pp. 445-449, (1994)

[8]

Rhoads G.G., Dahlen G., Berg K., Morton N.E., Dannenberg A.L., Lp(a) lipoprotein as a risk factor for myocardial infarction, JAMA, 256, pp. 2540-2544, (1986)

[9]

Grossman R.M., Delaney R.J., Brinton E.A., Carter D.M., Gottlieb A.B., Hypertriglyceridemia in patients with psoriasis treated with cyclosporine, J Am Acad Dermatol, 25, pp. 648-651, (1991)

[10]

Izaki S., Yamamoto T., Goto Y., Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation, Br J Dermatol, 134, pp. 1060-1064, (1996)

← 1 2 3 →